GOSS

Gossamer Bio Inc

1.25
-0.06 (-4.58%)
Company Name Stock Ticker Symbol Market Type
Gossamer Bio Inc GOSS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -4.58% 1.25 12:54:38
Open Price Low Price High Price Close Price Prev Close
1.28 1.24 1.31 1.31
more quote information »

Recent News

Date Time Source Heading
5/18/202307:05BWGossamer Bio Announces TORREY Data to be Featured at..
5/10/202309:22EDGARAmended Statement of Ownership (sc 13g/a)
5/09/202316:25EDGARStatement of Changes in Beneficial Ownership (4)
5/09/202316:20EDGARStatement of Changes in Beneficial Ownership (4)
5/09/202316:13EDGARStatement of Changes in Beneficial Ownership (4)
5/09/202316:05EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/09/202316:04EDGARCurrent Report Filing (8-k)
5/09/202316:01BWGossamer Bio Announces First Quarter 2023 Financial Results..
5/05/202311:54EDGARAmended Statement of Ownership (sc 13g/a)
4/28/202316:04EDGARAnnual Report to Security Holders (ars)
4/17/202316:02EDGARProxy Statement - Notice of Shareholders Meeting..
4/03/202316:02EDGARCurrent Report Filing (8-k)
3/22/202317:25EDGARStatement of Changes in Beneficial Ownership (4)
3/22/202317:15EDGARStatement of Changes in Beneficial Ownership (4)
3/20/202309:23EDGARStatement of Changes in Beneficial Ownership (4)
3/20/202309:22EDGARStatement of Changes in Beneficial Ownership (4)
3/17/202307:43EDGARAnnual Report (10-k)
3/17/202307:41EDGARCurrent Report Filing (8-k)
3/17/202307:31BWGossamer Bio Announces Fourth Quarter and Full-Year 2022..
2/14/202316:20EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202312:17EDGARAmended Statement of Ownership (sc 13g/a)
2/01/202316:55EDGARAmended Statement of Ownership (sc 13g/a)
1/10/202307:55EDGARStatement of Ownership (sc 13g)
1/04/202316:22EDGARStatement of Ownership (sc 13g)
12/09/202217:22EDGARStatement of Changes in Beneficial Ownership (4)
12/09/202217:21EDGARStatement of Changes in Beneficial Ownership (4)
12/09/202217:19EDGARStatement of Changes in Beneficial Ownership (4)
12/09/202217:16EDGARStatement of Changes in Beneficial Ownership (4)
12/09/202217:14EDGARStatement of Changes in Beneficial Ownership (4)
12/08/202206:15TRMNGossamer Bio (GOSS) Gets a Buy from H.C. Wainwright
12/07/202211:25TRMNUBS Keeps Their Buy Rating on Gossamer Bio (GOSS)
12/07/202211:25TRMNGoldman Sachs Sticks to Their Buy Rating for Gossamer Bio..
12/07/202207:35TRMNSMBC Nikko downgrades Gossamer Bio (GOSS) to a Hold
12/07/202207:35TRMNGossamer Bio (GOSS) Gets a Buy from Raymond James
12/06/202214:35TRMNWedbush Keeps Their Buy Rating on Gossamer Bio (GOSS)
12/06/202211:00TRMNGossamer Bio Tanks after Phase 2 Study Results in PAH
12/06/202207:37EDGARCurrent Report Filing (8-k)
12/06/202207:15BWGossamer Bio Announces Seralutinib Meets Primary Endpoint in..
11/29/202223:15TRMNGossamer Bio (GOSS) Receives a Buy from SVB Securities
11/18/202206:45TRMNWedbush Sticks to Their Buy Rating for Gossamer Bio (GOSS)
11/08/202206:21TRMNAnalysts Have Conflicting Sentiments on These Healthcare..
11/04/202213:45TRMNWedbush Sticks to Their Buy Rating for Gossamer Bio (GOSS)
11/03/202216:04EDGARQuarterly Report (10-q)
11/03/202216:01EDGARCurrent Report Filing (8-k)
11/03/202216:01BWGossamer Bio Announces Third Quarter 2022 Financial Results..
10/27/202217:05EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
10/25/202216:58EDGARStatement of Changes in Beneficial Ownership (4)
10/24/202208:30TRMNGoldman Sachs Says These 2 Buy-Rated Stocks Have at Least..
10/13/202208:55TRMNGossamer Bio (GOSS) Gets a Buy from H.C. Wainwright
9/19/202206:45TRMNGossamer Bio (GOSS) Gets a Buy from Wedbush